Floatz logo

Guanabenz

Nonalcoholic Fatty Liver

Yokohama City UniversitySmall moleculePhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
95/ 100

Competitive context

8 Active assets in the Nonalcoholic Fatty Liver cohort.

Asset / SponsorPhaseRating
Denifanstat
Sagimet Biosciences Inc.
Phase 3BB
Zoladex
Aristotle University Of Thessaloniki
Phase 4BB
MARBLE DUST
Aristotle University Of Thessaloniki
Phase 4BB
Pioglitazone
The University of Texas Medical Branch, Galveston
Phase 4BB
pxl770
Poxel SA
Phase 2BB

View all 12 →

Same molecule, other indications

Guanabenz is also rated in:

Nonalcoholic SteatohepatitisDormant
CCC
Indicative ·
53 / 100
View asset →
relapsing-remitting multiple sclerosisDormant
CC
Indicative ·
41 / 100
View asset →
multiple sclerosisDormant
C
Indicative ·
37 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →